{"ORPHApacket":[{"ORPHApacketID":"329341","date":"2019-12-06 03:43:38","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"329341","Name":[{"lang":"en","label":"Limbic encephalitis with DPP6 antibodies"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_329341","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Non-paraneoplastic limbic encephalitis"}],"ORPHA":"163918","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_163918"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Limbic encephalitis with DPP6 antibodies is a rare brain inflammatory disease characterized by subacute or insidious onset of variable neurological features including cognitive dysfunction (memory impairment, hallucinations, confusion, amnesia), central hyperexcitability (agitation, tremor, myoclonus, exaggerated startle), brain stem involvement (dysphagia, dysarthia, ataxia) and disturbed sleep. Symptoms of dysautonomia include diarrhea, gastroparesis, and constipation."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adult"}]}]}],"SynonymList":[{"count":"2","Synonym":[{"lang":"en","label":"Limbic encephalitis with DPPX antibodies"},{"lang":"en","label":"Limbic encephalitis with dipeptidyl-peptidase 6 antibodies"}]}]}]}